MAP1LC3A and acute lymphoblastic leukemia: These observations indicate that in primary ALL cells with active MAPK/ERK signaling, the drugs cooperatively decrease mTOR activity and stimulate LC3 processing and relocalization, likely reflecting increased autophagy.